Article Text

Download PDFPDF
Oxcarbazepine is no more effective than placebo for reducing manic symptoms of bipolar I disorder in children and adolescents

Statistics from

OpenUrlCrossRefPubMedWeb of Science

Q Is oxcarbazepine safe and effective for the treatment of children and adolescents with bipolar disorder?


Embedded ImageDesign:

Randomised controlled trial.

Embedded ImageAllocation:


Embedded ImageBlinding:

Double blind.

Embedded ImageFollow-up period:

Seven weeks.

Embedded ImageSetting:

Twenty outpatient centres, USA; time period not stated.

Embedded ImagePatients:

116 child and adolescent outpatients (aged 7–18 years) with DSM-IV bipolar I disorder (confirmed by Schedule for Affective Disorders and Schizophrenia for School Age Children – Present and Lifetime Version), and experiencing a manic or mixed episode (baseline score ⩾ 20 on the Young Mania Rating Scale (YMRS)). Exclusions: current primary DSM-IV schizophrenia, delirium, substance induced mood disorder, anorexia, bulimia, or autism; …

View Full Text


  • For correspondence: Dr Karen D Wagner, Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77755-0188, USA; kwagner{at}

  • Source of funding: Novartis Pharmaceuticals.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.